Replies to post #214707 on Biotech Values

[DewDiligence]

APLS IPOs 12.3M* shares @$14.00 (midpoint of range):

$APLS Apellis pharmaceuticals 10.71M shares #IPO priced at $14. Will commence trading tomorrow 11/9

— Odi Bruckman (@odibro) November 8, 2017

This is the second go-round for Apellis, who pulled its IPO plan in early 2016 due to (bear) market conditions.

*Assuming exercise of underwriter’s option.